Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Chongsuvivatwong, V; Chariyalertsak, S; McNeil, E; Aiyarak, S; Hutamai, S; Dupont, H L; Jiang, Z D; Kalambaheti, T; Tonyong, W; Thitiphuree, S; Steffen, R (2009). Epidemiology of travelers' diarrhea in Thailand. Journal of Travel Medicine, 16(3):179-185.

Meraz, I M; Jiang, Z D; Ericsson, C D; Bourgeois, A L; Steffen, R; Taylor, D N; Hernandez, N; DuPont, H L (2008). Enterotoxigenic Escherichia coli and Diffusely Adherent E coli as Likely Causes of a Proportion of Pathogen-Negative Travelers’ Diarrhea-A PCR-Based Study. Journal of Travel Medicine, 15(6):412-418.

DuPont, H L; Haake, R; Taylor, D N; Ericsson, C D; Jiang, Z D; Okhuysen, P C; Steffen, R (2007). Rifaximin treatment of pathogen-negative travelers' diarrhea. Journal of Travel Medicine, 14(1):16-19.

Taylor, D N; Bourgeois, A L; Ericsson, C D; Steffen, R; Jiang, Z D; Halpern, J; Haake, R; Dupont, H L (2006). A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. The American Journal of Tropical Medicine and Hygiene, 74(6):1060-1066.

Infante, R M; Ericsson, C D; Jiang, Z D; Ke, S; Steffen, R; Riopel, L; Sack, D A; DuPont, H L (2004). Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy. Clinical Gastroenterology and Hepatology, 2(2):135-138.

Steffen, R; Sack, D A; Riopel, L; Jiang, Z D; StĂĽrchler, M; Ericsson, C D; Lowe, B; Waiyaki, P; White, M; DuPont, H L (2003). Therapy of travelers' diarrhea with rifaximin on various continents. American Journal of Gastroenterology, 98(5):1073-1078.

This list was generated on Wed Apr 24 00:43:36 2019 CEST.